A new study suggests that obese persons with type 2 diabetes should be the first in line for weight loss surgery, over obese persons without the disease.
The study was commissioned in the journal The Lancer Diabetes and Endocrinology and it was conducted by an international team of scientists. The study examined data from another study, called Swedish Obese Subjects.
Bariatric surgery is more commonly known as weight loss surgery. Of course, there are many types of surgery that treat weight problems, but bariatric surgery is the most popular of them. It involves a reduction of the stomach’s size. This type of surgery has shown great improvements not only in weight reduction, but also in the patient’s general health, because it reduces the risk of diabetes, heart attack, and cancer.
Obesity is one of the leading causes of type 2 diabetes, which is the most common form of diabetes. Type 2 diabetes manifests itself in persons who lose the ability to produce enough insulin to maintain a normal concentration of sugar in the blood. It eventually leads to hyperglycemia, characterized by higher blood sugar levels.
What the study found is that the vast majority of the healthcare systems give access to weight loss surgery according only to their boy mass index. That means the higher the body mass index you have, you will be prioritized for surgery.
The research calls for a prioritization of patients with type 2 diabetes, even if they are not as obese as the other patients who do not suffer from the disease. It has been suggested before by other research teams that patients should be treated according to the intensity of their diabetes, rather than just by their body mass index alone.
The Swedish Obese Subjects study included over 2,000 participants who underwent weight loss surgery over a 15 year period from 1987 to 2001. The research team said that the total costs after the sturgery (including drugs, hospital care) were higher in the case of the persons without diabetes or with prediabetes than in those who suffered from the disease. Researchers believe that the lower costs can be explained by the remission of diabetes in the patients who underwent bariatric surgery.
Not only that the overall costs are lower, but they also are far more effective on patients with type 2 diabetes. These patients are suffering from more than one condition, therefore, from an ethical point of view, the body mass index should not be the only signal that bariatric surgery is needed.
Photo Credits wikimedia.org